These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 3928801

  • 1. Hereditary tyrosinemia. Formation of succinylacetone-amino acid adducts.
    Manabe S, Sassa S, Kappas A.
    J Exp Med; 1985 Sep 01; 162(3):1060-74. PubMed ID: 3928801
    [Abstract] [Full Text] [Related]

  • 2. Identification of 4,6-dioxoheptanoic acid (succinylacetone), 3,5-dioxooctanedioic acid (succinylacetoacetate) and 4-Oxo-6-hydroxyheptanoic acid in the urine from patients with hereditary tyrosinemia.
    Lindblad B, Steen G.
    Biomed Mass Spectrom; 1982 Oct 01; 9(10):419-24. PubMed ID: 7171740
    [Abstract] [Full Text] [Related]

  • 3. Urinary excretion of succinylacetone and delta-aminolevulinic acid in patients with hereditary tyrosinemia.
    Christensen E, Jacobsen BB, Gregersen N, Hjeds H, Pedersen JB, Brandt NJ, Baekmark UB.
    Clin Chim Acta; 1981 Nov 11; 116(3):331-41. PubMed ID: 7296896
    [Abstract] [Full Text] [Related]

  • 4. Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone.
    Sassa S, Kappas A.
    J Clin Invest; 1983 Mar 11; 71(3):625-34. PubMed ID: 6826727
    [Abstract] [Full Text] [Related]

  • 5. Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia.
    Grenier A, Lescault A, Laberge C, Gagné R, Mamer O.
    Clin Chim Acta; 1982 Aug 04; 123(1-2):93-9. PubMed ID: 7116642
    [Abstract] [Full Text] [Related]

  • 6. Urinary excretion of deuterated metabolites in patients with tyrosinemia type I after oral loading with deuterated L-tyrosine.
    Wadman SK, Duran M, Ketting D, Bruinvis L, van Sprang FJ, Berger R, Smit GP, Steinmann B, Leonard JV, Divry P, Farriaux JP, Cartigny B.
    Clin Chim Acta; 1983 May 30; 130(2):231-8. PubMed ID: 6872257
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Contribution of extrahepatic tissues to biochemical abnormalities in hereditary tyrosinemia type I: study of three patients after liver transplantation.
    Tuchman M, Freese DK, Sharp HL, Ramnaraine ML, Ascher N, Bloomer JR.
    J Pediatr; 1987 Mar 30; 110(3):399-403. PubMed ID: 3546650
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1.
    Bain MD, Purkiss P, Jones M, Bingham P, Stacey TE, Chalmers RA.
    Eur J Pediatr; 1990 Jun 30; 149(9):637-9. PubMed ID: 2373116
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Deficiency of fumarylacetoacetase in a patient with hereditary tyrosinemia.
    Berger R, Smit GP, Stoker-de Vries SA, Duran M, Ketting D, Wadman SK.
    Clin Chim Acta; 1981 Jul 18; 114(1):37-44. PubMed ID: 7249373
    [Abstract] [Full Text] [Related]

  • 17. Hereditary tyrosinaemia type I: a long-term study of the relationship between the urinary excretions of succinylacetone and delta-aminolevulinic acid.
    Schierbeek H, Beukeveld GJ, van Faassen H, van Spronsen FJ, Bijsterveld K, Venekamp-Hoolsema EE, Wolthers BG, Smit GP.
    J Inherit Metab Dis; 1993 Jul 18; 16(6):1034-40. PubMed ID: 8127053
    [Abstract] [Full Text] [Related]

  • 18. Hereditary tyrosinemia of chronic course without rickets and renal tubular dysfunction.
    Søvik O, Kvittingen EA, Steen-Johnsen J, Halvorsen S.
    Acta Paediatr Scand; 1990 Nov 18; 79(11):1063-8. PubMed ID: 2267924
    [Abstract] [Full Text] [Related]

  • 19. Hereditary tyrosinemia type I--an overview.
    Kvittingen EA.
    Scand J Clin Lab Invest Suppl; 1986 Nov 18; 184():27-34. PubMed ID: 3296130
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.